About
BioFoundry of regenerative tissue
Areas of Focus
Categories
Tissue EngineeringBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
30
By Phase
PHASE1/PHASE2: 2PHASE1: 1
By Status
RECRUITING: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06072040Lead Sponsor
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia
PHASE1/PHASE2Recruiting
10 participants
Started: Jan 26, 2024 · Completed: Jun 30, 2026
NCT06078566Lead Sponsor
Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201
PHASE1/PHASE2Recruiting
10 participants
Started: Jan 26, 2024 · Completed: Jun 30, 2026
NCT06225336Lead Sponsor
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)
PHASE1Enrolling by invitation
10 participants
Started: Nov 4, 2022 · Completed: May 31, 2025
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...